GB0029919D0 - Helicobacter pylori prime & boost vaccination - Google Patents

Helicobacter pylori prime & boost vaccination

Info

Publication number
GB0029919D0
GB0029919D0 GBGB0029919.8A GB0029919A GB0029919D0 GB 0029919 D0 GB0029919 D0 GB 0029919D0 GB 0029919 A GB0029919 A GB 0029919A GB 0029919 D0 GB0029919 D0 GB 0029919D0
Authority
GB
United Kingdom
Prior art keywords
prime
helicobacter pylori
boost vaccination
vaccination
boost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0029919.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to GBGB0029919.8A priority Critical patent/GB0029919D0/en
Publication of GB0029919D0 publication Critical patent/GB0029919D0/en
Priority to AU2002220908A priority patent/AU2002220908A1/en
Priority to PCT/GB2001/005416 priority patent/WO2002045741A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0029919.8A 2000-12-07 2000-12-07 Helicobacter pylori prime & boost vaccination Ceased GB0029919D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0029919.8A GB0029919D0 (en) 2000-12-07 2000-12-07 Helicobacter pylori prime & boost vaccination
AU2002220908A AU2002220908A1 (en) 2000-12-07 2001-12-07 Helicobacter pylori prime and boost vaccination comprising caga and nap antigens
PCT/GB2001/005416 WO2002045741A2 (en) 2000-12-07 2001-12-07 Helicobacter pylori prime and boost vaccination comprising caga and nap antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0029919.8A GB0029919D0 (en) 2000-12-07 2000-12-07 Helicobacter pylori prime & boost vaccination

Publications (1)

Publication Number Publication Date
GB0029919D0 true GB0029919D0 (en) 2001-01-24

Family

ID=9904670

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0029919.8A Ceased GB0029919D0 (en) 2000-12-07 2000-12-07 Helicobacter pylori prime & boost vaccination

Country Status (3)

Country Link
AU (1) AU2002220908A1 (en)
GB (1) GB0029919D0 (en)
WO (1) WO2002045741A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025429A1 (en) 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
JP2001500738A (en) 1996-09-17 2001-01-23 カイロン コーポレイション Compositions and methods for treating intracellular diseases
CA2458854A1 (en) * 2001-08-31 2003-03-06 Chiron Srl Helicobacter pylori vaccination
GB0302218D0 (en) 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
DE60328481D1 (en) * 2002-05-14 2009-09-03 Novartis Vaccines & Diagnostic SLEEP-CAPACITIVE VACCINE CONTAINING THE ADJUVANZ CHITOSAN AND MENIGOKOKKENANTIGENE
WO2005115449A1 (en) * 2004-05-28 2005-12-08 Alk-Abelló A/S Method of treating allergy and infection by eliciting an iga antibody response
EP1767214B1 (en) * 2005-09-23 2009-05-13 Gianfranco Del Prete Use of neurotrophil activating protein of helicobacter pylori (HP-NAP) and/or of its portions as adjuvants for the development of T helper type 1 (TH1) immune responses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0877623A1 (en) * 1995-07-07 1998-11-18 Oravax, Inc. Intranasal vaccination against gastrointestinal disease
JP2002512619A (en) * 1997-04-30 2002-04-23 メリウクス オラバクス Anti-Helicobacter vaccine composition for use in the subdiaphragm systemic route and combined mucosal / parenteral immunization
DE69922364T2 (en) * 1998-04-30 2005-11-03 Chiron S.R.L. Method of immunization against and treatment of H. pylori infections

Also Published As

Publication number Publication date
WO2002045741A2 (en) 2002-06-13
AU2002220908A1 (en) 2002-06-18
WO2002045741A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HUP0301092A3 (en) Vaccine
AU4433702A (en) Vaccines
AU2001280908A1 (en) Rotavirus vaccine formulations
AU1591402A (en) Vaccine
HUP0302612A3 (en) Salmonella vaccine
IL156992A0 (en) Novel receptors for helicobacter pylori and use thereof
GB0014288D0 (en) Vaccine
GB0029919D0 (en) Helicobacter pylori prime & boost vaccination
GB0017239D0 (en) Detection of helicobacter pylori
AU142324S (en) Connector
GB0017149D0 (en) Helicobacter pylori mutants
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
AU5676801A (en) Preparations for diagnosing infection with helicobacter pylori
GB0010371D0 (en) Helicobacter pylori antigens
GB0025694D0 (en) Vaccine
GB0125665D0 (en) Helicobacter pylori vaccination
AU2001268885A1 (en) Helicobacter dd-heptosyltransferase
GB0010370D0 (en) Helicobacter pylori antigens
AU142323S (en) Connector
AU2002328123A1 (en) Helicobacter pylori vaccination
AU142322S (en) Connector
GB0015722D0 (en) Vaccine
AU4789400A (en) (helicobacter pylori) antigens
GB0205018D0 (en) Heliobacter pylori vaccination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)